Clinigen Group plc, the global pharmaceutical and services company, today announces that it has completed the acquisition of CSM Parent, Inc., which was announced on 27 September 2018.
Following Admission of the Placing Shares on 1 October 2018 (details of the Placing having been announced by the Company on 27 September 2018 to coincide with the announcement of the Acquisition), the Company now has in issue 131,949,754 ordinary shares of 0.1p each, with voting rights. Clinigen does not hold any shares in treasury.
Date: October 8, 2018
Source: MarketScreener
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.